- Home
- FUN vs CRNX Comparison
FUN vs CRNX Comparison
Compare FUN & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FUN
- CRNX
- Stock Information
- Founded
- FUN 1983
- CRNX 2008
- Country
- FUN United States
- CRNX United States
- Employees
- FUN N/A
- CRNX N/A
- Industry
- FUN Services-Misc. Amusement & Recreation
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- FUN Consumer Discretionary
- CRNX Health Care
- Exchange
- FUN Nasdaq
- CRNX Nasdaq
- Market Cap
- FUN 4.7B
- CRNX 5.2B
- IPO Year
- FUN 1987
- CRNX 2018
- Fundamental
- Price
- FUN $48.62
- CRNX $53.60
- Analyst Decision
- FUN Strong Buy
- CRNX Strong Buy
- Analyst Count
- FUN 14
- CRNX 10
- Target Price
- FUN $56.07
- CRNX $74.40
- AVG Volume (30 Days)
- FUN 1.5M
- CRNX 760.3K
- Earning Date
- FUN 02-13-2025
- CRNX 11-12-2024
- Dividend Yield
- FUN 1.23%
- CRNX N/A
- EPS Growth
- FUN N/A
- CRNX N/A
- EPS
- FUN 0.37
- CRNX N/A
- Revenue
- FUN $2,392,739,000.00
- CRNX $1,038,999.00
- Revenue This Year
- FUN $84.75
- CRNX N/A
- Revenue Next Year
- FUN $3.91
- CRNX $195.21
- P/E Ratio
- FUN $133.07
- CRNX N/A
- Revenue Growth
- FUN 33.41
- CRNX N/A
- 52 Week Low
- FUN $35.93
- CRNX $33.67
- 52 Week High
- FUN $58.70
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- FUN 61.79
- CRNX 43.52
- Support Level
- FUN $45.26
- CRNX $50.82
- Resistance Level
- FUN $48.41
- CRNX $56.15
- Average True Range (ATR)
- FUN 1.70
- CRNX 2.79
- MACD
- FUN -0.10
- CRNX -0.50
- Stochastic Oscillator
- FUN 91.80
- CRNX 29.24
About FUN Cedar Fair L.P.
Six Flags Entertainment Corp is North America's regional amusement-resort operator with 27 amusement parks, 15 water parks and nine resort properties across 17 states in the U.S., Canada and Mexico. Six Flags provides coasters, themed rides, thrilling water parks, resorts and a portfolio of beloved intellectual property such as Looney Tunes, DC Comics and PEANUTS.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors.